Announcements Trials
Browse Landscape

Phase

Phase 1/2 2

Status

Terminated 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2Dermatologic 1

Conditions

Carcinoma, Hepatocellular 4Colorectal Neoplasms 3Recurrence 2Pancreatic Neoplasms 2Liver Neoplasms 2Neoplasm Metastasis 1Liver Cirrhosis 1Hepatitis C, Chronic 1Hepatitis C 1

Interventions

Oxaliplatin 10Gemcitabine 8Cisplatin 7Hepatectomy 6Fluorouracil 6Radiofrequency Ablation 5Liver Transplantation 5Irinotecan 5Capecitabine 5lenvatinib 4Paclitaxel 4Neoadjuvant Therapy 4Folfox protocol 4Cetuximab 4Aspirin 4tislelizumab 3Surgical Procedures, Operative 3Nivolumab 3Carboplatin 3titanium silicide 2durvalumab 2apatinib 2Trastuzumab 2S 1 (combination) 2Leucovorin 2Lamivudine 2Introns 2Ethiodized Oil 2Drug Therapy 2DNA, Mitochondrial 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Recurrence × Introns × Gastrointestinal × Clear all
NCT01545141 2023-10-27

Chemokine-Modulatory Regimen for Recurrent Resectable Colorectal Cancer

Roswell Park Cancer Institute

Phase 1/2 Terminated
15 enrolled 9 charts
Gastrointestinal

Neoplasm Metastasis, Recurrence, Colorectal Neoplasms

NCT00234182 2005-12-01

Postoperative Adjuvant Therapy With Recombinant Interferon-Alpha Following Curative Resection of HCC

The University of Hong Kong

Phase 1/2 Completed
84 enrolled
Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡